[1] 中华医学会病理学分会消化疾病学组筹备组. 胃食管反流病、Barrett 食管和食管胃交界腺癌病理诊断共识[J]. 中华病理学杂志, 2017, 46(2): 79-83. [2] LEE A L, GOLDSTEIN R S. Gastroesophageal reflux disease in COPD: links and risks[J]. Int J Chron Obstruct Pulmon Dis, 2015, 10: 1935-1949. [3] BONACIN D, FABIJANI D, RADI M, et al. Gastroesophageal reflux disease and pulmonary function: a potential role of the dead space extension[J]. Med Sci Monit, 2012, 18(5): CR271-CR275. [4] SAKAE T M, PIZZICHINI M M, TEIXEIRA P J, et al. Exacerbations of COPD and symptoms of gastroesophageal reflux: a systematic review and meta-analysis[J]. J Bras Pneumol, 2013, 39(3): 259-271. [5] AJMERA M, RAVAL A D, SHEN C, et al. Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis[J]. Int J Chron Obstruct Pulmon Dis, 2014, 9: 339-348. [6] KIM J, LEE J H, KIM Y, et al. Association between chronic obstructive pulmonary disease and gastroesophageal reflux disease: a national cross-sectional cohort study[J]. BMC Pulm Med, 2013, 13: 51. [7] RAVELLI A M, PANAROTTO M B, VERDONI L, et al. Pulmonary aspiration shown by scintigraphy in gastroesophageal reflux-related respiratory disease[J]. Chest, 2006,130(5): 1520-1526. [8] IRWIN R S. Chronic cough due to gastroesophageal reflux disease: ACCP evidence-based clinical practice guidelines[J]. Chest, 2006, 129(1 Suppl): S80-S94. [9] VAKIL N. Acid inhibition and infections outside the gastrointestinal tract[J]. Am J Gastroenterol, 2009, 104(Suppl 2): S17-S20. [10] AYBAY C, IMIR T, OKUR H. The effect of omeprazole on human natural killer cell activity[J]. Gen Pharmacol, 1995, 26(6): 1413-1418. [11] SCARINGI L, CORNACCHIONE P, FETTUCCIARI K, et al. Activity inhibition of cytolytic lymphocytes by omeprazole[J]. Scand J Immunol, 1996, 44(3): 204-214. [12] YOSHIDA N, YOSHIKAWA T, TANAKA Y, et al. A new mechanism for anti-inflammatory actions of proton pump inhibitors-inhibitory effects on neutrophil-endothelial cell interactions[J]. Aliment Pharmacol Ther, 2000, 14(Suppl 1): 74-81. [13] 叶俏. 特发性肺纤维化与胃食管反流的研究进展[J]. 慢性病学杂志, 2015, 16(1): 39-43. [14] SHIMAZU R, AOKI S, KURATOMI Y. Experimental pulmonary fibrosis in rats with chronic gastric acid reflux esophagitis[J]. Auris Nasus Larynx, 2015, 42(5): 382-384. [15] RAGHU G, MEYER K C. Silent gastro-oesophageal reflux and microaspiration in IPF: mounting evidence for anti-reflux therapy[J]. Eur Respir J, 2012,39(2): 242-245. [16] KING C, NATHAN S D. Identification and treatment of comorbidities in idiopathic pulmonary fibrosis and other fibrotic lung diseases[J]. Curr Opin Pulm Med, 2013,19(5): 466-473. [17] 陈碧, 蒋捍东. 胃食管反流病与特发性肺纤维化[J]. 中华结核和呼吸杂志, 2016,39(2): 137-139. [18] LEE J S, COLLARD H R, ANSTROM K J, et al. Anti-acid treatment and disease progression in idiopathic pulmonary fibrosis: an analysis of data from three randomised controlled trials[J]. Lancet Respir Med, 2013,1(5): 369-376. [19] LEE J S, RYU J H, ELICKER B M, et al. Gastroesophageal reflux therapy is associated with longer survival in patients with idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2011,184(12): 1390-1394. [20] 姚东英, 刘菲. 胃食管反流病与慢性咳嗽的关系[J]. 国际消化病杂志, 2011,31(4): 201-203. [21] 弓三东, 崔立红. 胃食管反流性咳嗽发病机制的研究进展[J]. 世界华人消化杂志, 2014,22(19): 2665-2670. [22] SMITH J A, DECALMER S, KELSALL A, et al. Acoustic cough-reflux associations in chronic cough: potential triggers and mechanisms[J]. Gastroenterology, 2010,139(3): 754-762. [23] ATES F, VAEZI M F. Insight into the relationship between gastroesophageal reflux disease and asthma[J]. Gastroenterol Hepatol(N Y), 2014,10(11): 729-736. [24] HERSHCOVICI T, JHA L K, GADAM R, et al. The relationship between type 2 diabetes mellitus and failure to proton pump inhibitor treatment in gastroesophageal reflux disease[J]. J Clin Gastroenterol, 2012,46(8): 662-668. [25] ARAS G, KANMAZ D, KADAKAL F, et al. Gastroesophageal reflux disease in our asthma patients: the presence of dysphagia can influence pulmonary function[J]. Multidiscip Respir Med, 2012,7(1): 53. [26] 刘教春, 郑林, 詹志刚, 等. 24h动态PH监测在支气管哮喘合并胃食管反流病的临床研究[J]. 临床肺科杂志, 2016,21(09): 1642-1646. [27] 朱莎, 李芳. 胃食管反流源性哮喘发病机制的研究现状[J]. 大连医科大学学报, 2013,35(6): 611-613. [28] BROERS C, TACK J, PAUWELS A. Review article: gastro-oesophageal reflux disease in asthma and chronic obstructive pulmonary disease[J]. Aliment Pharmacol Ther, 2018,47(2): 176-191. [29] CHRISTIE J D, EDWARDS L B, KUCHERYAVAYA A Y, et al. The registry of the international society for heart and lung transplantation: 29th adult lung and heart-lung transplant report-2012[J]. J Heart Lung Transplant, 2012,31(10): 1073-1086. [30] HATHORN K E, CHAN W W, LO W K. Role of gastroesophageal reflux disease in lung transplantation[J]. World J Transplant, 2017,7(2): 103-116. [31] 陈军, 方泽民, 魏翔, 等. 肺移植术后胃食管反流病预防和治疗的初步经验[J]. 临床外科杂志, 2015,23(10): 776-778. [32] SUEN H C, HENDRIX H, PATTERSON G A. Physiologic consequences of pneumonectomy. consequences on the esophageal function[J]. Chest Surg Clin N Am, 1999,9(2): 475-483, xiii. [33] HADJILIADIS D, DUANE D R, STEELE M P, et al. Gastroesophageal reflux disease in lung transplant recipients[J]. Clin Transplant, 2003,17(4): 363-368. [34] FISICHELLA P M, REDER N P, GAGERMEIER J, et al. Usefulness of pH monitoring in predicting the survival status of patients with scleroderma awaiting lung transplantation[J]. J Surg Res, 2014,189(2): 232-237. |